Virtu Financial’s Kymera Therapeutics KYMR Stock Holding History

Virtu Financial’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	+12,556	New	+$1.08M	0.05%	234
2026 Q1	–	Sell	-27,283	Closed	-$2.12M	–	2001
2025 Q4	$2.12M	Buy	+27,283	New	+$1.84M	0.08%	151
2025 Q3	–	Sell	-10,362	Closed	-$452K	–	1802
2025 Q2	$452K	Buy	+10,362	New	+$357K	0.02%	609
2024 Q2	–	Sell	-5,147	Closed	-$207K	–	1617
2024 Q1	$207K	Buy	+5,147	New	+$184K	0.02%	773
2021 Q3	–	Sell	-6,085	Closed	-$295K	–	1743
2021 Q2	$295K	Sell	6,085 -5,773	-49%	-$251K	0.03%	734
2021 Q1	$461K	Buy	+11,858	New	+$714K	0.03%	559

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Virtu Financial's KYMR Position: Q2 2026 in Review

Virtu Financial opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 12,556 shares worth $1.44M. The stake represents 0.05% of the portfolio and ranks #234 among its holdings. This is a return to the name: Virtu Financial previously reported a position in KYMR as recently as Q4 2025.

Virtu Financial first reported a position in KYMR in Q1 2021 and has held it in 6 quarters since. The position peaked at $2.12M in Q4 2025. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Virtu Financial held 12,556 shares of Kymera Therapeutics worth $1.44M as of Q2 2026.
Kymera Therapeutics was a new Virtu Financial position in Q2 2026.
Kymera Therapeutics made up 0.05% of Virtu Financial's portfolio in Q2 2026, its #234 holding.
Virtu Financial first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 6 quarters since.
Virtu Financial's Kymera Therapeutics position peaked at $2.12M in Q4 2025.
276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.